Community-based heat-sensitive moxibustion for primary hypertension: study protocol for a randomized controlled trial with patient-preference arms

Xu Zhou, Shuqing Li, Ling Li, Guihua Deng, Li Dai, Luyu Chai, Qingni Wu, Ziqian Yao, Minchao Deng, Weifeng Zhu, Yong Fu, Xin Sun, Xu Zhou, Shuqing Li, Ling Li, Guihua Deng, Li Dai, Luyu Chai, Qingni Wu, Ziqian Yao, Minchao Deng, Weifeng Zhu, Yong Fu, Xin Sun

Abstract

Background: Low- and middle-income countries have a high prevalence of primary hypertension, but its treatment and control are often low. Heat-sensitive moxibustion (HSM), an innovative acupoint stimulation technique, may be effective for treating hypertension and thus used appropriately in primary healthcare. The objective of this study is to investigate whether HSM is effective and safe for the treatment of primary hypertension in the community.

Methods: This study is a multicenter, pragmatic, randomized controlled trial (RCT) with patient-preference arms. Four hundred patients with primary hypertension from seven communities will be enrolled. Initially, the communities will be randomly assigned into two study clusters, one using compulsory randomization and the other allowing treatment selection by patient preferences. Then, patients in the compulsory randomization cluster will be randomized to receive HSM plus their original antihypertensive regimen (HSM group) or only their original antihypertensive regimen (control group) for 6 months. Patients in the patient preference cluster may choose to receive HSM or control if they have a preference; otherwise, patients will be randomly assigned. The primary outcome is the change in systolic blood pressure from baseline; secondary outcomes include change in diastolic blood pressure, dosage of antihypertensive drugs, quality of life (QoL), severity of hypertensive symptoms, and incidence of cardiovascular events. Patient compliance with the HSM regimen, the cost-effectiveness ratio, and safety outcomes will also be evaluated. Outcome data will be collected at 6 monthly visits.

Discussion: This trial will provide important evidence regarding HSM as a technique for primary hypertension in primary healthcare settings. Given the randomization with patient preferences considered, the trial will also allow analyzing patient-preference effects and the comparison of randomized and nonrandomized samples, to improve the robustness and extrapolation of study conclusions.

Trial registration: ClinicalTrials.gov NCT04788563 . Registered on March 9, 2021.

Keywords: Community healthcare; Heat-sensitive moxibustion; Pragmatic trial; Primary hypertension.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart of the study. Abbreviation: HSM, heat-sensitive moxibustion
Fig. 2
Fig. 2
Schedule of study visits

References

    1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi: 10.1038/s41581-019-0244-2.
    1. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Bärnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catalá-López F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki MES, Murray CJL. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165–182. doi: 10.1001/jama.2016.19043.
    1. Xie X, He T, Kang J, Siscovick DS, Li Y, Pagán JA. Cost-effectiveness analysis of intensive hypertension control in China. Prev Med. 2018;111:110–114. doi: 10.1016/j.ypmed.2018.02.033.
    1. Wang Y, Peng X, Nie X, Chen L, Weldon R, Zhang W, Xiao D, Cai J. Burden of hypertension in China over the past decades: Systematic analysis of prevalence, treatment and control of hypertension. Eur J Prev Cardiol. 2016;23(8):792–800. doi: 10.1177/2047487315617105.
    1. Li X, Krumholz HM, Yip W, et al. Quality of primary health care in China: challenges and recommendations. Lancet (London, England) 2020;395(10239):1802–1812. doi: 10.1016/S0140-6736(20)30122-7.
    1. Su M, Zhang Q, Bai X, et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet (London, England) 2017;390(10112):2559–2568. doi: 10.1016/S0140-6736(17)32476-5.
    1. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S, PURE (Prospective Urban Rural Epidemiology) Study investigators Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968. doi: 10.1001/jama.2013.184182.
    1. Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL, Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L, COBRA-BPS Study Group A Community-Based Intervention for Managing Hypertension in Rural South Asia. New Engl J Med. 2020;382(8):717–726. doi: 10.1056/NEJMoa1911965.
    1. Chen R, Chen M, Xiong J, Su T, Zhou M, Sun J, Chi Z, Zhang B, Xie D. Comparative effectiveness of the deqi sensation and non-deqi by moxibustion stimulation: a multicenter prospective cohort study in the treatment of knee osteoarthritis. Evid-Based Complement Altern Med eCAM. 2013;2013:906947. doi: 10.1155/2013/906947.
    1. Chen R, Chen M, Su T, Zhou M, Sun J, Xiong J, Chi Z, Xie D, Zhang B. Heat-sensitive moxibustion in patients with osteoarthritis of the knee: a three-armed multiCenter randomised active control trial. Acupunct Med. 2015;33(4):262–269. doi: 10.1136/acupmed-2014-010740.
    1. Chen R, Chen M, Su T, Zhou M, Sun J, Xiong J, Chi Z, Xie D, Zhang B. A 3-Arm, Randomized, Controlled Trial of Heat-Sensitive Moxibustion Therapy to Determine Superior Effect among Patients with Lumbar Disc Herniation. Evid Based Complement Alternat Med. 2014;2014:154941–154947. doi: 10.1155/2014/154941.
    1. Xiong J, Liu Z, Chen R, Xie D, Chi Z, Zhang B. Effectiveness and safety of heat-sensitive moxibustion on bronchial asthma: a meta-analysis of randomized control trials. J Tradit Chin Med. 2014;34(4):392–400. doi: 10.1016/S0254-6272(15)30038-8.
    1. Lee HS, Yu YC, Kim ST, Kim KS. Effects of moxibustion on blood pressure and renal function in spontaneously hypertensive rats. Am J Chin Med. 1997;25(1):21–26. doi: 10.1142/S0192415X97000056.
    1. Guan Y, Zhang H, Zhang H, et al. Effect of grain-size moxa cone on blood pressure and mTOR protein expression in spontaneous hypertensive rats. Chin J Integr Med Cardio-/Cerebrovascuiar Dis. 2016;14(4):361–363.
    1. Zhou X, Wu Q, Liu M, Zhu W, Ren Q, Wang Y, Sun X, Chen J. Moxibustion for Essential Hypertension and Hypertensive Symptoms: A Systematic Review of 18 Randomized Controlled Trials. Complement Med Res. 2021;28(5):435–445. doi: 10.1159/000513701:1-11.
    1. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004. doi: 10.1097/HJH.0000000000002453.
    1. Specialty Committee of Heat-sensitive Moxibustion of WFCMS. Heat-sensitive Moxibustion Technical Practice Guideline. World Chin Med. 2017;12(8):1959-1964.
    1. EQ-5D-5L User Guide, 2019. 2019. . Accessed April 30, 2021.
    1. Zheng X. The Guidance for Clinical Research of New Chinese Medicines. Beijing: Medicine Science and Technology Press of China; 2002.
    1. Xu J, Deng H, Shen X. Safety of moxibustion: a systematic review of case reports. Evid Based Complement Alternat Med. 2014;2014:783704–783710. doi: 10.1155/2014/783704.
    1. Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1(1):51–54.
    1. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, for the CONSORT NPT Group CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med. 2017;167(1):40–47. doi: 10.7326/M17-0046.
    1. Halpern SD. Evaluating preference effects in partially unblinded, randomized clinical trials. J Clin Epidemiol. 2003;56(2):109–115. doi: 10.1016/S0895-4356(02)00598-X.
    1. Cao HJ, Liu JP, Hu H, Wang NS. Using a partially randomized patient preference study design to evaluate the therapeutic effect of acupuncture and cupping therapy for fibromyalgia: study protocol for a partially randomized controlled trial. Trials. 2014;15(1):280. doi: 10.1186/1745-6215-15-280.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj